MENLO PARK, Calif., Aug. 20, 2019 /PRNewswire/ -- Today Health2047 Inc. is launching Zing Health, a tech-enabled health plan for those who are underserved by existing insurance plans. Co-founded by Health2047 with ex

LOS ANGELES, Aug. 20, 2019 /PRNewswire/ -- Zynx Health™,  market leader in providing evidence- and experience-based clinical improvement solutions since 1996, announced today the release

HOUSTON, Aug. 20, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced approval by the Emory University Clinical Trial Review Committee (CTRC) to move forward with an

LUND, Sweden, Aug. 20, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company will host a Capital Markets Day in Stockholm on 9 October, 2019, for investors, analysts and media.Presentations will be ma

BURLINGTON, ON, Aug. 20, 2019 /PRNewswire/ - Rapid Dose Therapeutics Corp. (CSE: DOSE), ("RDT") announced today the com

SMITHS FALLS, ON, Aug. 20, 2019 /PRNewswire/ - Canopy Growth Corporation (TSX: WEED), (NYSE:

OLDWICK, N.J., Aug. 20, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced the appointment of Sherron Kell, MD, MPH as Senior Vice President of Clinical Development. Dr. Kell will lead the PRV-031 (tepliz

SANTA BARBARA, Calif., Aug. 20, 2019 /PRNewswire/ -- Comvita, the pioneer and trusted global leader in Manuka Honey, revealed today the market's only line of UMF

NASHVILLE, Tenn. and DALLAS, Aug. 20, 2019 /PRNewswire/ -- Pharos Capital-backed Verdi Oncology, Inc. ("Verdi") has entered two new markets in the past two months. Nashville Oncology Associates (NOA), led by founders Dr. Karl Rogers and Dr. Carl Willis, joined Verdi in Jul

HOLLAND, Mich., Aug. 20, 2019 /PRNewswire/ -- Genesis Innovation Group and their cultivate(MD) Capital Fund II, LP, a fund focused on investments into early stage healthcare companies with innovative technologies, announced their investment into Grand Rapids, MI based